Gut–liver feedback may prolong cortisol exposure by suppressing its breakdown
In a subset of aging humans, impaired liver cortisol disposal could sustain a gut inflammatory signal that further impairs disposal. The proposed return pathway would be rejected in the tested setting if adequately represented, specifically perturbed pathways show no effect at physiological exposures.
Omega Point 1.5
Stage of verification
- Hypothesis published2026-10-10
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolism and energy
Cortisol inactivation
The metabolic conversion of cortisol into inactive products
Where this hypothesis actsHepatic cortisol disposal potentially suppressed by inflammation in a subset of aging humans
Hypotheses on this target 1
Inhibition
Activation1
Function preservation
Supplementation
Feedback restoration
Direct measurement

What is proposed
Activation
Restore cortisol inactivation through the candidate hepatic disposal pathway
With whatNot stated in the record
HowPathway-specific restoration is proposed, but the enzyme or reaction sequence and a selective restoration method remain unidentified
Possible result
Possible lower free-cortisol exposure, weaker gut-liver feedback and improved sleep and activity recovery
From the recordRestoring the clearance arm could reduce harmful SPV_12 coupling and permit sleep and ordinary-activity recovery while preserving the necessary initial stress response.

Immune response
Inflammatory response
The body's inflammatory reaction to microbial or tissue-derived stimuli
Where this hypothesis actsEnteric-glial and immune relay under sustained free-cortisol exposure, with a proposed liver-active output
Hypotheses on this target 5
Inhibition
Activation
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration2
Rhythm restoration
What is proposed
Selectively interrupt the gut inflammatory relay
HowSelective gut interruption with mediator add-back at supported hepatic exposure; exclude direct hepatocyte effects. No selective regimen is established
Possible result
Possible increased hepatic cortisol inactivation and reduced exposure-mediated gut inflammatory output
From the recordAt fixed free cortisol and non-gut inflammatory inputs, selective gut interruption should increase pathway-resolved hepatic inactivation after direct hepatocyte exposure to the intervention and active products is excluded.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
An ordinary stress could leave the body struggling to recover because organs keep renewing one another’s response. The unexpected move is that cortisol might remain active because the liver disposes of it too slowly, while the gut sends back signals that further slow disposal. This is a proposal generated by the pipeline, not a measured explanation of human aging.
- Inflammation is proposed to suppress a liver pathway that irreversibly disposes of cortisol.
- Slower disposal prolongs free cortisol, the fraction not bound to blood proteins, after external stress ends and hormone secretion begins to normalize.
- Prolonged exposure is proposed to activate inflammatory responses involving enteric glia and immune cells.
- An unidentified gut-derived signal reaches the liver and further suppresses cortisol disposal.
- If the interaction is strong enough under normal hormone regulation, a response that would fade becomes a persistent, mutually maintained state; weaker interaction could merely delay recovery.
A basin drains slowly, and the high water level triggers a device that partly closes the drain, keeping the water high even after the tap is turned down.
Where the picture breaks: The body can adjust hormone production, binding and movement between tissues, while the gut signal must survive transport to the liver. The basin picture cannot establish whether these combined processes sustain a persistent state or simply slow its disappearance.
- Master questionstep 01 of 04
Radically slowing human aging is the overarching aim.
Rests on: The supplied goal establishes the desired outcome without specifying a mechanism or intervention.
Stated in the chain - Goal pillarstep 02 of 04
Responses that help individual parts of the body cope are proposed to reinforce one another and accelerate vulnerability with age.
Rests on: Moving from slowing aging to this explanation requires a connection between mutually reinforcing coping responses and increasing age-related vulnerability.
LeapThe master question supplies an aim, but no basis for selecting mutually reinforcing local responses as a cause of accelerating vulnerability; the screened sources do not establish that connection.
- Gap questionstep 03 of 04
Organs might actively prolong one another’s stress responses, or they might merely respond to the same cause and recover at different speeds.
Rests on: The preceding stage’s claim of mutual reinforcement requires separating actual two-way effects from shared causes and unequal recovery times.
Stated in the chain - Hypothesisstep 04 of 04
In some aging humans, inflammation is proposed to slow a liver process that inactivates cortisol, extending exposure after stress ends. That exposure could activate enteric glia, cells supporting the gut’s nervous system, together with immune cells; their inflammatory output could reach the liver and further suppress disposal.
Rests on: The preceding question motivates looking for reciprocal organ effects, but the particular liver process, gut response and returning inflammatory signal are proposed additions.
AssumptionThe proposal explicitly assumes an inflammation-sensitive liver disposal pathway, a relevant response in older-human gut cells, adequate delivery of a liver-suppressing gut signal, and sufficiently strong interaction to sustain exposure under normal hormone regulation. None is established for this population by the supplied sources.
What is carried, and what is not. One screened source, Critical care medicine (2015), reports longer persistence of free cortisol in severe infection, but does not locate the cause in the liver or establish persistence after infection resolves; the supplied Physiological reviews (2013) abstract describes an enzyme, a protein that catalyzes a chemical reaction, capable of inactivating these hormones, but does not establish the proposed inflammatory liver defect. No screened source establishes the proposed gut-to-liver return signal or the sequence end to end, and The Journal of endocrinology (1981) abstract reports no significant prolongation of cortisol persistence under acute stress in male guinea-pigs, a result that does not settle the older-human proposal.
Where the reasoning is carried by something unstated · 2
- Goal pillar. The master question supplies an aim, but no basis for selecting mutually reinforcing local responses as a cause of accelerating vulnerability; the screened sources do not establish that connection. Establish the missing link before relying on this step.
- Hypothesis. The proposal explicitly assumes an inflammation-sensitive liver disposal pathway, a relevant response in older-human gut cells, adequate delivery of a liver-suppressing gut signal, and sufficiently strong interaction to sustain exposure under normal hormone regulation. None is established for this population by the supplied sources.
How a result here could mislead · 3
- Persistent cortisol could be attributed to impaired liver disposal even if continued secretion, temporary binding, movement between tissues or regeneration of active hormone explains the measurements. What closes it: The proposed measurements must distinguish these processes and independently establish the liver’s contribution. If they cannot be separated, the result must remain bounded rather than assigned to a specific liver defect; changes in a candidate enzyme’s abundance alone do not establish changed irreversible disposal.
- Interrupting a gut process could appear to reveal a gut-to-liver signal when the intervention acts directly on liver cells. Restoring suppression with an arbitrarily concentrated gut sample could also show an effect that never occurs at the liver in a person. What closes it: At fixed free cortisol and other inflammatory inputs, exclude direct liver effects of the intervention and its active products. Adding back the candidate signal must reproduce a measured or independently constrained liver exposure profile, and that supported range must overlap the range that actually suppresses liver disposal.
- Improved disposal followed by lower cortisol could be read as proof of a self-maintaining loop, although it also fits a one-way liver effect or a system that eventually recovers without intervention. Increased secretion could cancel the exposure change altogether. What closes it: The separate condition in which cortisol can change must show the predicted secondary sequence: lower cortisol, lower gut output and additional disposal recovery. Restoring cortisol exposure must remove that secondary component, while independently measured response strengths, transport and regulatory delays must predict persistence rather than slow recovery on new observations; compensatory secretion must be included.
What would make this wrong. The proposed reciprocal mechanism would fail in a tested subgroup if a specifically verified interruption of the represented gut pathway, under supported human exposure conditions and with direct liver effects excluded, produced no change in independently measured liver cortisol disposal. Its stronger claim of persistence would fail if independently measured interactions and hormone regulation predicted only eventual recovery and new observations supported that prediction. A negative result in a preparation missing necessary immune cells or adequate signal delivery would not settle the full hypothesis.
What it would change. If the mechanism held, some prolonged post-stress states in aging humans would depend on reciprocal gut–liver effects, making restoration of hormone disposal a candidate route to recovery that would need to preserve useful stress responses and defense against infection. Establishing this loop would not exclude the supplied muscle–liver recycling or kidney–muscle alternatives as coexisting causes. Better sleep, recovery after activity and radical slowing of human aging would still require separate evidence, as would the prevalence of this mechanism beyond the tested subgroup.
Sources read · 6
The Role of Race, Sex, and Age in Circadian Disruption and Metabolic Disorders. · Gastro hep advances · 2022
“Older people were noted to have decreased expression of anti-inflammatory clock genes compared to younger people, possibly leading to increased rates of obesity, diabetes, hyperlipidemia, and hypertension.”
Does not settle: The source does not establish hepatic cortisol inactivation or clearance, inflammatory suppression of a specific hepatic enzyme pathway, prolonged free-cortisol exposure after stress, an enteric-glial and immune relay to the liver, reciprocal gut–liver feedback, physiological coupling strength, older-human glial responses, liver-active mediators, recovery times, or effects of restoring cortisol clearance.
Local cortisol/corticosterone activation in skin physiology and pathology. · Journal of dermatological science · 2016
“The 11β-HSD2 isoform, which catalyzes nicotinamide adenine dinucleotide+-dependent inactivation of cortisol/corticosterone to cortisone/11-DHC, is highly expressed in distal nephrons, the colon, sweat glands, and the placenta.”
Does not settle: The source does not establish a hepatic cortisol-inactivation defect, inflammatory suppression of such a pathway, prolonged free-cortisol exposure, an aging-human enteric-glial response, a liver-active gut mediator, reciprocal gut–liver feedback, physiological coupling strength, persistence after stress, or effects of restoring clearance.
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. · Physiological reviews · 2013
“11β-HSD2 is a high-affinity dehydrogenase that inactivates glucocorticoids.”
Does not settle: The abstract does not establish inflammatory suppression of hepatic cortisol inactivation in older humans, prolonged free-cortisol exposure after stress, an enteric-glial and immune relay, a liver-active mediator, reciprocal gut-liver feedback, physiological coupling sufficient for persistence, or effects of restoring hepatic clearance.
Reversible increase in maximal cortisol secretion rate in septic shock. · Critical care medicine · 2015
“Free cortisol half-life was significantly increased in septic shock (4.6 min [2.2, 6.3 min]) and sepsis (3.0 min [2.3, 4.8 min] when compared with controls (2.0 min [1.2, 2.6 min]) (both p < 0.004).”
Does not settle: The source does not localize reduced cortisol elimination to the liver, identify a specific cortisol-inactivation pathway or its inflammatory suppression, establish an enteric-glial or gut–liver feedback relay, demonstrate persistence after stress or infection resolves, isolate an aging-human subset, or show physiologically sufficient reciprocal coupling under normal cortisol production and hypothalamic-pituitary-adrenal feedback.
Effects of acute neurotrophic stress on peripheral metabolism of cortisol in conscious male guinea-pigs. · The Journal of endocrinology · 1981
“The lack of significant differences in the slopes of the second exponential phase of the disappearance curves indicated that the stress did not significantly increase the half-lie of cortisol.”
Does not settle: This acute 3-hour stress study in adult male guinea-pigs does not establish cortisol kinetics in aging humans, localization of clearance changes to the liver, suppression of a specific hepatic inactivation pathway by inflammation, a gut–liver inflammatory relay, persistence after stress ends, or reciprocal feedback under physiological hypothalamic-pituitary-adrenal regulation.
Road traffic noise exposure and its impact on health: evidence from animal and human studies-chronic stress, inflammation, and oxidative stress as key components of the complex downstream pathway underlying noise-induced non-auditory health effects. · Environmental science and pollution research international · 2024
“However, in cases of chronic stress, dysfunction in the HPA axis occurs, and buffering mechanisms may prove insufficient to return to baseline conditions.”
Does not settle: The source does not establish impaired hepatic cortisol inactivation, inflammatory suppression of a specific clearance pathway, prolonged free-cortisol exposure after stress ends, an enteric-glial gut–liver relay, reciprocal feedback, or physiological sufficiency in aging humans.
The gap this hypothesis explains
What is measured here stands in for what matters, and may not track it.
Does human aging prolong stress through organs amplifying each other, or through shared triggers and different recovery speeds?
Original wording · exactly as the pipeline generated it
Does human aging amplify ordinary stress through reciprocal organ feedback, or do common inputs and unequal recovery delays create an apparent loop while each organ remains independently stable?
What this question is asking
The question concerns why changes in organ function might persist after an everyday stress has ended, and whether aging changes that process. It asks whether organs repeatedly drive further changes in one another, or whether shared triggers, lingering damage, and different recovery speeds explain the same pattern without such reinforcement. The proposed measurements concern mobilization, meaning the body's activation of resources to respond, and perfusion, meaning blood flow through tissue. The distinguishing comparison is whether these changes fade during recovery or become amplified again because of effects passing between organs, and whether that differs with age. The question presents competing explanations rather than an established claim that aging creates a harmful loop.
- Human aging
- Changes in people as they grow older. Here, aging is the proposed influence on the strength or duration of stress responses, but the supplied sources do not establish that influence.
- Ordinary stress
- An everyday challenge that provokes a bodily response. The supplied input does not specify the challenge, its intensity, or its duration.
- Reciprocal organ feedback
- A change in one organ affects another, and an effect from the second returns to influence the first. Feedback describes a pattern of causation; observing changes in both organs does not by itself establish it.
- Amplification
- A disturbance becomes stronger through the effects it produces. In this question, the proposed reinforcement passes between organs and may renew or prolong their responses.
- Shared triggers or common inputs
- Influences that affect more than one organ. They can produce related changes without those organs causing the changes in one another.
- Recovery delays
- Differences in how long responses take to fade after a challenge. Different delays can produce a sequence of changes that resembles feedback.
- Independent stability
- An organ's tendency to return toward its usual state after a disturbance without requiring reinforcement from another organ. It does not mean that the organ has no connections to the rest of the body.
- Residual injury or lingering damage
- Damage that remains after the original challenge has ended. The question includes it as a possible reason for slow recovery, not as a demonstrated finding in aging humans.
- Mobilization
- Activation of the body's resources to respond to a challenge. The supplied input does not specify which measurement represents this broad process.
- Perfusion
- Blood flow through tissue. Its deviation from the usual level is one of the outcomes the gap detail wants explained.
- Baseline
- A reference state, such as a measurement before stress. Returning toward baseline describes recovery relative to that reference, without specifying how much recovery is sufficient.
- Response trajectory
- The pattern of a measurement over time. A trajectory can show persistence or recovery without revealing what caused the pattern.
- Brain-signal–fluid coupling
- A measured relationship between a brain blood-oxygen-related signal and cerebrospinal fluid, the fluid surrounding the brain and spinal cord. S1 reports changes in this relationship; coupling alone does not establish which process causes another.
- Association
- A measured relationship between changes or observations. An association does not, by itself, show that one causes the other.
- Acute pancreatitis
- A sudden inflammatory illness of the pancreas, an organ involved in digestion and blood-sugar regulation. S2 addresses lung and intestinal injury in this disease setting.
- Inflammatory activators and mediators
- Substances that initiate or carry processes involved in inflammation, the body's response to injury or other challenges. These are broad functional classes; S2 describes their participation in mutually reinforcing activity.
- Signaling inside cells
- Processes through which a cell responds to a signal and changes its activity. In S2's account, these processes connect inflammatory activation to the release of further inflammatory mediators.
- Vicious cycle
- A reinforcing process in which harmful effects help sustain or increase further harmful effects. S2 uses this description in its disease context; that does not establish the proposed loop in ordinary stress or aging.
- Endpoint
- An outcome used to assess the question. Here, the intended outcomes include the persistence, decline, or renewed amplification of mobilization and tissue blood-flow changes.
- Aging strengthens reciprocal amplification Under this outcome, a stress-related change in one organ would affect another, whose response would feed back and reinforce the first change. Stronger reinforcement with age would help explain renewed or prolonged disturbance after the original trigger ends, so recovery could not be understood solely from each organ's separate recovery speed.
- Shared triggers and separate recovery explain persistence Under this outcome, several organs would respond to a common influence and then recover at different speeds, potentially with lingering damage slowing some responses. Their staggered changes could resemble a loop even while each organ tends back toward its usual state without reinforcement from another organ. Attributing that pattern to reciprocal amplification would assign causation to the sequence itself.
- Both mechanisms contribute Under this outcome, shared triggers or lingering damage would sustain some changes while reciprocal effects between organs would reinforce others. The duration of the response alone would not identify how much each mechanism contributes or whether aging changes either contribution.
A shared trigger can affect several organs, and different recovery speeds can make their changes appear in sequence. That sequence alone does not establish that one organ caused the next change or that the effects returned to reinforce the first. If reciprocal reinforcement exists, an organ's continuing disturbance could depend on signals arriving from elsewhere even after the original stress ends. If recovery is independent, treating the sequence as a reinforcing loop would misidentify what sustains the changes. Neither supplied source establishes which explanation applies to human aging.
RL-2/3 human response trajectories and sleep-related muscle evidence reveal delays and persistence, but do not identify reciprocal causal gain.
Mobilization and perfusion deviations decay within acute or subacute recovery windows, without renewed amplification after ordinary stress ends.
Determine whether cross-organ feedback causes persistence or whether shared inputs, residual injury, and independent recovery delays explain the same trajectories.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
SCOUT 2, from steroid biotransformation and endogenous pharmacokinetics, conditional: In a subset of aging humans, inflammatory suppression of a specific hepatic cortisol-inactivation pathway could prolong biologically active free-cortisol exposure after the initiating external stress ends and adrenal secretion begins to normalize. Sustained exposure could activate an enteric-glial and immune inflammatory relay whose liver-reaching output further suppresses hepatic inactivation. The frozen retained state is reciprocal gut-liver control of endogenous steroid exposure. Systemic clearance alone cannot localize the defect to liver. The enzyme pathway, inflammatory suppression, older-human glial response and physiologically sufficient liver-active mediator remain unknown. The contextual chronic-glucocorticoid mouse mechanism supplies no numerical human dose or duration equivalence. Strong persistence requires sufficient coupling under physiological hormone production, transport and hypothalamic-pituitary-adrenal feedback; tissue reciprocity might instead be stable and merely alter recovery time. Continuing psychosocial stress, administered steroids and learned neural memory are not necessary components, but they, residual infection, injury and retained inflammatory memory remain alternatives or coexisting causes. Restoring the clearance arm could reduce harmful SPV_12 coupling and permit sleep and ordinary-activity recovery while preserving the necessary initial stress response. This consequence remains conditional on preserved useful glucocorticoid actions, host defense and stress competence, and on compensatory secretion not canceling the exposure change.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Steroid biotransformation and endogenous pharmacokinetics motivate distinctions among secretion, binding, distribution, reversible regeneration and irreversible disposal. Their mapping to this older-human phenotype remains an unverified assumption to be tested by kinetic identification and regional or pathway attribution. is contextual mouse chronic-glucocorticoid material involving inflammatory enteric glia, CSF1-dependent monocyte recruitment and TNF-associated intestinal inflammation. It is not an archived source. Older-human cell-specific responses, physiologically adequate gut-to-liver transport, hepatic suppression and sufficient reciprocal dynamics are additional assumptions. Direct immune suppression and glial proinflammatory action may coexist across cells and exposure windows; this contextual mechanism does not overturn established steroid indications.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
First separate adrenal secretion, reversible tissue regeneration, binding, distribution, extrahepatic metabolism and irreversible disposal using specialist isotope kinetics, serial free and total cortisol, binding measurements and steroid metabolomics over repeated circadian cycles. Establish identifiability; report bounds when these determinants cannot be separated. Specify whether clearance is referenced to free or total concentration. Establish a hepatic contribution independently through regional or enzyme-pathway measurements. E_H denotes an unidentified candidate hepatic disposal pathway, not an identified enzyme. Before claiming an enzyme-specific defect, identify the enzyme or defined reaction sequence, labeled products, irreversible fate, hepatic contribution and response to participant-range inflammatory exposure. Measure substrate-to-product conversion and candidate enzyme abundance or activity under matched substrate conditions; a changed expression marker alone is insufficient. A validated pathway-specific loss-and-restoration experiment would need to change irreversible disposal as predicted while alternative pathways and tissue viability are characterized. Until these steps identify E_H, the parent remains a conditional pathway-class hypothesis. Next replay participant-measured free-cortisol concentrations, durations and recovery periods in human enteric preparations containing glia and necessary immune cells, distinguishing glial responses from direct immune glucocorticoid suppression. M_G denotes an unidentified liver-active gut output. Determine its cellular source, production rate, molecular identity or explicitly characterized active fraction, transport, binding, degradation and removal, and the resulting hepatic concentration-time profile. Local gut abundance or culture-supernatant concentration cannot substitute for hepatic exposure. If direct hepatic exposure measurements are unavailable, use a prospectively specified transport model with independently constrained parameters and uncertainty bounds. Test whether the supported exposure range overlaps the measured hepatic inhibitory range. Suppression only at higher concentrations demonstrates pharmacological sufficiency, not operation of the human return arm. At fixed free cortisol and non-gut inflammatory inputs, selective gut interruption should increase pathway-resolved hepatic inactivation after direct hepatocyte exposure to the intervention and active products is excluded. Add-back using the supported hepatic exposure profile should restore suppression. This establishes a return arm only if specificity and physiological delivery are adequate. In a separate unclamped condition, the initial clearance improvement should lower free cortisol, reduce gut output and yield additional clearance recovery. Cortisol replacement should remove the exposure-mediated secondary component; the initial direct consequence of gut interruption can remain. Hepatic restoration followed by replacement alone fits a one-way downstream model. Estimate both tissue response functions, mediator transport, cortisol production and disposal, and adrenal feedback with delays. Test whether their independently measured ranges predict a persistent post-stress state and its interruption, versus stable delayed recovery, on new observations. Include compensatory secretion after increased clearance rather than treating it as zero. A persistent state may coexist with negative feedback without requiring that one local positive gain exceed every opposing process; the complete physiological dynamics must determine the outcome. If compensation restores exposure, predict reduced or absent exposure-mediated functional benefit rather than inferring benefit from clearance alone. Fixed apparatus cortisol tests exposure-response behavior only. Null results constrain adequately represented, specifically perturbed pathways within the tested physiological range. Sleep, activity, host defense and the response to a subsequent safe stress require separate assessment.
States a measurable outcome; comparing rivals needs more conditions. The chunk predicts increased hepatic inactivation after selective gut interruption and restored suppression after add-back under specified conditions. These qualitative outcomes are measurable. No rival prediction is supplied. The chunk predicts directional physiological changes and conditional removal or reduction of an exposure-mediated effect. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
All kinetic, pathway, mediator and exposure measurements are proposed. Even specialist methods may leave secretion, regeneration and disposal nonidentifiable. No specific E_H enzyme, M_G mediator, selective restoration or quantitative adrenal-feedback model is supplied. A hepatocyte-glia pair may omit recruited monocytes or other essential immune cells; include them or restrict conclusions to represented links. Circulation, mediator delivery and endocrine regulation require explicit representation. Physiological add-back requires a measured or defensibly bounded hepatic exposure profile, not an arbitrary culture concentration. Gut interruption with mediator add-back and hepatic restoration with cortisol replacement answer different questions. Broad steroid-synthesis inhibition does not isolate the mechanism, and no selective clinical regimen is established.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
First separate adrenal secretion, reversible tissue regeneration, binding, distribution, extrahepatic metabolism and irreversible disposal using specialist isotope kinetics, serial free and total cortisol, binding measurements and steroid metabolomics over repeated circadian cycles. Establish identifiability; report bounds when these determinants cannot be separated. Specify whether clearance is referenced to free or total concentration. Establish a hepatic contribution independently through regional or enzyme-pathway measurements. E_H denotes an unidentified candidate hepatic disposal pathway, not an identified enzyme. Before claiming an enzyme-specific defect, identify the enzyme or defined reaction sequence, labeled products, irreversible fate, hepatic contribution and response to participant-range inflammatory exposure. Measure substrate-to-product conversion and candidate enzyme abundance or activity under matched substrate conditions; a changed expression marker alone is insufficient. A validated pathway-specific loss-and-restoration experiment would need to change irreversible disposal as predicted while alternative pathways and tissue viability are characterized. Until these steps identify E_H, the parent remains a conditional pathway-class hypothesis. Next replay participant-measured free-cortisol concentrations, durations and recovery periods in human enteric preparations containing glia and necessary immune cells, distinguishing glial responses from direct immune glucocorticoid suppression. M_G denotes an unidentified liver-active gut output. Determine its cellular source, production rate, molecular identity or explicitly characterized active fraction, transport, binding, degradation and removal, and the resulting hepatic concentration-time profile. Local gut abundance or culture-supernatant concentration cannot substitute for hepatic exposure. If direct hepatic exposure measurements are unavailable, use a prospectively specified transport model with independently constrained parameters and uncertainty bounds. Test whether the supported exposure range overlaps the measured hepatic inhibitory range. Suppression only at higher concentrations demonstrates pharmacological sufficiency, not operation of the human return arm. At fixed free cortisol and non-gut inflammatory inputs, selective gut interruption should increase pathway-resolved hepatic inactivation after direct hepatocyte exposure to the intervention and active products is excluded. Add-back using the supported hepatic exposure profile should restore suppression. This establishes a return arm only if specificity and physiological delivery are adequate. In a separate unclamped condition, the initial clearance improvement should lower free cortisol, reduce gut output and yield additional clearance recovery. Cortisol replacement should remove the exposure-mediated secondary component; the initial direct consequence of gut interruption can remain. Hepatic restoration followed by replacement alone fits a one-way downstream model. Estimate both tissue response functions, mediator transport, cortisol production and disposal, and adrenal feedback with delays. Test whether their independently measured ranges predict a persistent post-stress state and its interruption, versus stable delayed recovery, on new observations. Include compensatory secretion after increased clearance rather than treating it as zero. A persistent state may coexist with negative feedback without requiring that one local positive gain exceed every opposing process; the complete physiological dynamics must determine the outcome. If compensation restores exposure, predict reduced or absent exposure-mediated functional benefit rather than inferring benefit from clearance alone. Fixed apparatus cortisol tests exposure-response behavior only. Null results constrain adequately represented, specifically perturbed pathways within the tested physiological range. Sleep, activity, host defense and the response to a subsequent safe stress require separate assessment.
- Rival 01 of 02What would separate them
Liver energy demand from lactate recycling may sustain a costly muscle–liver feedback loop predicts: First establish whether a quantitatively important excess-recycling phenotype exists after matched mild activity. Combine complementary glucose and lactate tracers, regional muscle balance and an identifiable non-steady-state carbon model. Account for circulating glucose, glycogen, alternative lactate fates, other glucose sources and compartment exchange. For a defined muscle compartment, lactate-pool change equals local formation plus uptake minus oxidation, other disposal and export; net vascular release equals export minus uptake. Arteriovenous balance alone cannot identify production. Report uncertainty bounds where formation, uptake or disposal cannot be separated. Bound hepatic energetic expenditure using regional or independently validated mechanistic measurements; whole-body calorimetry, hepatic oxygen consumption alone and an ATP concentration alone cannot identify recycling-specific ATP demand. Define Q_H as hepatic ATP-equivalent turnover attributable to the relevant processing over a specified interval, R as a candidate demand-transmitting cardiovascular or endocrine relay, and Z as specified competing substrate, redox or secretory changes with a possible demand-independent action. These are experimental variables requiring identification, not observed pathways. Identify R's origin, muscle target, exposure-response relation, gain and delay. Validate a liver-restricted recycling perturbation and exclude direct muscle exposure to it or its active products. Match glucose concentration and delivery, insulin, oxygen, electrolytes, arterial lactate and independently imposed upstream inputs; independently replay altered substrate trajectories. Then add a demand-versus-collateral-output discrimination. In one experimental series, independently vary Q_H within the relevant hepatic compartment while matching the specified Z trajectories and allowing R to respond. The frozen mechanism predicts a change in R followed by a corresponding change in independently resolved muscle glycolytic production. In a complementary series, vary candidate Z trajectories while Q_H and upstream inputs are matched. A muscle response fully attributable to Z without an independently demonstrated Q_H-to-R effect supports collateral hepatic signaling rather than establishing the frozen mechanism. If Z is itself proposed to be R, first test whether changing Q_H causes its production; subsequent Z add-back at fixed Q_H tests downstream sufficiency only. Never clamp the actual mediator in a test intended to establish intact transmission. A validated restoration of the relevant hepatic demand during continued recycling reduction, at matched competing outputs, should restore R and muscle production if demand is the operative cause. Generic ATP consumption in another compartment, hypoxia, injury or altered ATP concentration does not qualify as equivalent demand restoration. Independent perturbations or a quantitatively identified dissociation must separate the effects; correlated measurements and statistical adjustment alone are insufficient. No qualifying manipulation is supplied. If separation is infeasible, even successful relay blockade and physiological add-back justify only liver-to-muscle signaling, leaving demand dependence unresolved. In separate mediation experiments, relay blockade should remove the transmitted muscle response and physiological R replacement should restore it despite reduced recycling. Independent glucose replacement should fail to restore the loop only if a non-glucose demand-dependent relay closes it; include the replacement's physiological production, delivery, endocrine and other-organ costs in whole-person accounting. A fall in net lactate release with unchanged formation does not confirm the mechanism. Compare complete coupled and uncoupled systems with matched substrates, hormones, oxygen, waste removal, tissue support and local history. Before testing persistence, specify individualized recovery ranges, required duration within those ranges, an observation horizon based on independently measured recovery distributions, and measurements of residual tissue injury and retained states. Estimate directed responses independently and predict held-out challenges. The strong claim additionally predicts a post-input state incompatible with measured stable-decay and local-memory alternatives, and termination of that state after specific return-path interruption. Longer recovery or a positive root of a local fitted model alone is insufficient; finite observation cannot prove indefinite persistence. Under common forcing, hepatic processing may fall while muscle production follows residual injury or upstream activation. Null results constrain only the tested subgroup and window when target engagement, specificity, sensitivity and pathway representation are adequate.
- Rival 02 of 02What would separate them
Potassium-driven acid retention may weaken muscle potassium uptake and amplify kidney stress predicts: Measure dietary potassium entry separately from activity-related redistribution, regional muscle potassium uptake and release, urinary potassium, urinary ammonium, titratable acid, bicarbonate excretion, acid production, nonrenal acid-base gains and losses, relevant extracellular volumes and buffering. Urinary net acid excretion is ammonium plus titratable acid minus bicarbonate, expressed as equivalent amounts over the same interval. Titratable acid is operationally the acid equivalents in urinary non-ammonium buffers determined by titration to a specified reference pH, with assay conventions reported. Whole-body acid retention requires an independent balance; buffering redistributes or binds retained acid equivalents rather than automatically eliminating them. Serial blood chemistry does not by itself establish the acid exposure at muscle. Identify the relevant acid-base species, pH and concentration-time trajectory reaching muscle using direct measurements where feasible or an independently validated transport-and-buffering model with uncertainty bounds. If the interval permits negligible or insufficient muscle exposure, the acute mechanism remains unsupported even with reduced ammonium excretion. Replay the participant-range muscle exposure at matched potassium, glucose, insulin, aldosterone and other relevant inputs, and measure regional uptake, release, dose-response and delay. Separately replay the resulting secondary potassium trajectory in renal preparations at matched acid exposure and other inputs; quantify total net acid disposal. Both independently estimated response functions and potassium and acid balances must predict the secondary coupled response on held-out ordinary challenges. A candidate muscle-specific intervention qualifies only if it selectively removes the acid-associated uptake defect while its independent effects on baseline transport, hormones and renal exposure are quantified. Test it in a crossed set of participant-relevant acid, potassium, hormonal and tissue states, including baseline-acid and open-path controls. Validate that direct-effect estimates transfer to the corresponding coupled states; do not subtract a single baseline effect from a nonlinear coupled response without demonstrating that transfer. Under the loop, interruption removes the predicted acid-mediated secondary potassium rise and renewed renal suppression beyond state-matched direct effects. Under primary renal or shared hormonal dysfunction, acid transmission is absent, too weak or too late, although nonspecific uptake enhancement or systemic alkali can still improve concentrations. If no selective interruption or defensible state-specific direct-effect bound is available, report the identified local responses and leave complete-loop rescue unresolved. Separately demonstrate that each protective function alone accommodates the same load over the same horizon and limits, with shared determinants and the other compartment's support specified, before interpreting joint indicator failure as failed redundancy. Follow later potassium release and eventual elimination. Acid exposure developing only after the relevant muscle response rejects the acute timing claim in the tested setting; a slower interaction remains a separate unestablished possibility. Null results require verified target engagement, adequate sensitivity, relevant exposures and represented pathways.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 2 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Abstract; The Gut Microbiota, Kynurenine Pathway, and Immune System Interaction in the Development of Brain Cancer..
2 papers retrieved around this hypothesis
- The Gut Microbiota, Kynurenine Pathway, and Immune System Interaction in the Development of Brain Cancer.PMID 33330446 · full_text · 80,016 characters stored
- Abstracteuropepmc:PMC:PMC12416199 · full_text · 546,538 characters stored
0 citation handles extracted; 2 Europe PMC searches run; 8 records examined; 2 sources stored for enrichment, 2 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.